CLINICAL_TRIALS
trial_result
· 2010-12-10
Clinical Trial Update: A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) [Phase 2]
Summary
This clinical trial update reports the completion of a Phase 2 study evaluating MK0249 for Attention-Deficit/Hyperactivity Disorder, with results posted on 2010…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) | Phase 2 | Status: COMPLETED | Results posted: 2010-12-10